Form 8-K - Current report:
SEC Accession No. 0001193125-23-035865
Filing Date
2023-02-13
Accepted
2023-02-13 16:20:07
Documents
15
Period of Report
2023-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d446963d8k.htm   iXBRL 8-K 33533
2 EX-99.1 d446963dex991.htm EX-99.1 23697
6 GRAPHIC g446963dsp5.jpg GRAPHIC 9837
7 GRAPHIC g446963dsp5a.jpg GRAPHIC 12789
  Complete submission text file 0001193125-23-035865.txt   217317

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctkb-20230213.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctkb-20230213_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctkb-20230213_pre.xml EX-101.PRE 10806
9 EXTRACTED XBRL INSTANCE DOCUMENT d446963d8k_htm.xml XML 3232
Mailing Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538
Business Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 (877) 922-9835
Cytek Biosciences, Inc. (Filer) CIK: 0001831915 (see all company filings)

EIN.: 472547526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40632 | Film No.: 23618783
SIC: 3826 Laboratory Analytical Instruments